Clinical Trials Logo

Persistent Atrial Fibrillation clinical trials

View clinical trials related to Persistent Atrial Fibrillation.

Filter by:

NCT ID: NCT06377046 Not yet recruiting - Atrial Fibrillation Clinical Trials

Accelerated Pacing in Patients Undergoing Pace-and-ablate Strategy With LBBAP: a Randomized Controlled Pilot Trial

PACE-AF
Start date: May 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to determine the effect of accelerated pacing (pacemaker lower rate programmed to 80bpm) compared to pacing at the standard programmed lower rate of 60bpm in symptomatic atrial fibrillation patients undergoing pace-and-ablate strategy with LBBAP. The main question it aims to answer is: - To determine the effect of accelerated pacing on health-related quality of life compared to the current standard of care. Secondary questions it aims to answer are: - To study the acute hemodynamic effect of different (accelerated) pacing rates on pulmonary capillary wedge pressure, cardiac output and arterial blood pressure among atrial fibrillation patients undergoing pace-and-ablate strategy. - To study the long-term effects (at 6 months) of accelerated pacing compared to the current standard of care among atrial fibrillation patients undergoing pace-and-ablate strategy on: - NT pro BNP levels - device detected atrial fibrillation burden and daily activity - echocardiographic measurements (LVEF, left ventricular ejection fraction; LVEDD, left ventricular end- diastolic diameter; LVESD, left ventricular end-systolic diameter; LAVI left atrial volume index; diastolic parameters; strain

NCT ID: NCT06260670 Completed - Clinical trials for Persistent Atrial Fibrillation

FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation

FLOW EVAL-AF
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

FLOW EVAL-AF is a prospective, observational, single center pilot trial. The FLOW EVAL-AF trial is designed to identify driver sources in patients with persistent or longstanding persistent AF using EGF mapping and describe the activation patterns observed from concomitant high density mapping of those regions.

NCT ID: NCT06232798 Recruiting - Clinical trials for Persistent Atrial Fibrillation

A Dual Energy Catheter (PFA and RFA) and a PFA Catheter for the Treatment of PeAF

PFA,RFA,PeAF
Start date: January 11, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to treatment of patients with persistent atrial fibrillation with PFA/RFA. 10 patients will be treated by PFA/RFA catheter or PFA catheter only. Participants will followed 1、3 month after catheter ablation

NCT ID: NCT06175234 Not yet recruiting - Atrial Fibrillation Clinical Trials

Feasibility Study on the FARAVIEW Technology

NAVIGATE PF
Start date: April 5, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to gather data regarding the utilization of the FARAVIEW™ feature of the RHYTHMIA HDx Mapping System when used in conjunction with the FARAWAVE NAV Pulsed Field Ablation catheter in subjects undergoing catheter-based endocardial mapping and catheter-based ablation treatment of Atrial Fibrillation.

NCT ID: NCT06165510 Not yet recruiting - Clinical trials for Persistent Atrial Fibrillation

Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation

CLIP-AF
Start date: January 2024
Phase: N/A
Study type: Interventional

A randomised controlled clinical trial to assess efficacy of convergent ablation with the LARIAT procedure, as compared to standard endocardial catheter ablation in patients with long-standing persistent atrial fibrillation (AF).

NCT ID: NCT06134752 Enrolling by invitation - Clinical trials for Persistent Atrial Fibrillation

Electroporation for Treatment of Atrial Fibrillation

ELECTROAF
Start date: December 5, 2023
Phase: N/A
Study type: Interventional

Comparison of pulmonary vein and left atrial posterior wall isolation durability and clinical outcome between radiofrequency and pulse field ablation in patients with persistent and longstanding persistent atrial fibrillation.

NCT ID: NCT06124690 Active, not recruiting - Clinical trials for Persistent Atrial Fibrillation

Persistent Atrial Fibrillation Without the Evidence of Low-voltage Areas

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

An effective therapy of persistent atrial fibrillation beyond pulmonary vein isolation remains unsatisfactory. Targeting endocardial low-voltage areas represents an approach of substrate modification. This prospective, randomized study investigated the efficacy of ablation of low-voltage areas versus PVI and additional linear ablations in patients with persistent atrial fibrillation in terms of single-procedure arrhythmia-free outcome and safety.

NCT ID: NCT06096337 Recruiting - Clinical trials for Persistent Atrial Fibrillation

Pulsed Field Ablation (PFA) Versus Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation

AVANT GUARD
Start date: December 28, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with persistent atrial fibrillation as compared to subjects who received an initial treatment with anti-arrhythmic drugs.

NCT ID: NCT06096246 Not yet recruiting - Clinical trials for Persistent Atrial Fibrillation

Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)

ORBICA-AF
Start date: April 5, 2024
Phase: N/A
Study type: Interventional

The main aim of the research is to investigate whether patients undergoing pulmonary vein isolation with catheter ablation for persistent atrial fibrillation (AF) will have lower rates of AF recurrence than those treated by DC cardioversion without an ablation procedure.

NCT ID: NCT05988411 Recruiting - Clinical trials for Paroxysmal Atrial Fibrillation

ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

Start date: December 7, 2023
Phase: N/A
Study type: Interventional

This is a Prospective, controlled, single-blind, randomized (2:1, Intervention:Control) clinical trial. The purpose of the study is to determine the role of adjunctive renal sympathetic denervation in the prevention of Atrial Fibrillation (AF) recurrence in patients with hypertension scheduled for a redo AF ablation procedure for paroxysmal or persistent AF. Patients will be randomized to either i) AF ablation (Control) or ii) AF ablation + renal sympathetic denervation (Intervention).